Cargando…
Secondary Immune Thrombocytopenia in Metastatic Renal Cell Carcinoma: A Case Report and Discussion of the Literature
Immune thrombocytopenia (ITP) is a rare paraneoplastic syndrome of solid tumor malignancies. In previously described cases of renal cell carcinoma (RCC) associated with secondary ITP, treatment has consisted of nephrectomy, splenectomy, and corticosteroids. Here, we describe a case of metastatic RCC...
Autores principales: | Cockrell, Dillon C., Kasthuri, Raj S., Altun, Ersan, Rose, Tracy L., Milowsky, Matthew I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772849/ https://www.ncbi.nlm.nih.gov/pubmed/33442354 http://dx.doi.org/10.1159/000511067 |
Ejemplares similares
-
Trends in Initial Systemic Therapy for Elderly Patients with Metastatic Clear Cell Renal Cell Carcinoma
por: Osterman, Chelsea K., et al.
Publicado: (2020) -
Drug-induced immune-mediated thrombocytopenia secondary to sunitinib in a patient with metastatic renal cell carcinoma: a case report
por: Ansari, Zia, et al.
Publicado: (2013) -
Severe immune thrombocytopenia induced by nivolumab in a patient with metastatic renal cell carcinoma
por: Hata, Shinro, et al.
Publicado: (2020) -
Pathobiology of Secondary Immune Thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2009) -
IMMUNE THROMBOCYTOPENIA SECONDARY TO COVID-19
por: AGRAWAL, AVNI, et al.
Publicado: (2021)